US Stock MarketDetailed Quotes

ELDN Eledon Pharmaceuticals

Watchlist
  • 2.970
  • +0.160+5.69%
Close Oct 18 16:00 ET
  • 2.970
  • +0.000+0.01%
Post 20:01 ET
122.91MMarket Cap-1125P/E (TTM)

Eledon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
40.06%14.5M
-2.17%10.87M
8.09%43M
2.97%10.34M
5.66%11.2M
11.54%10.35M
12.69%11.11M
7.90%39.78M
6.98%10.04M
0.88%10.6M
Selling and administrative expenses
39.42%4.4M
15.42%3.46M
-0.09%12.69M
17.24%3.27M
3.85%3.27M
-10.93%3.15M
-7.04%3M
-3.29%12.7M
-12.89%2.79M
10.46%3.15M
-General and administrative expense
39.42%4.4M
15.42%3.46M
-0.09%12.69M
17.24%3.27M
3.85%3.27M
-10.93%3.15M
-7.04%3M
-3.29%12.7M
-12.89%2.79M
10.46%3.15M
Research and development costs
40.34%10.11M
-8.67%7.41M
11.94%30.31M
-2.52%7.07M
6.43%7.93M
25.39%7.2M
22.28%8.11M
14.09%27.08M
17.28%7.25M
-2.69%7.45M
Operating profit
-40.06%-14.5M
2.17%-10.87M
-8.09%-43M
-2.97%-10.34M
-5.66%-11.2M
-11.54%-10.35M
-12.69%-11.11M
-7.90%-39.78M
-6.98%-10.04M
-0.88%-10.6M
Net non-operating interest income expense
Other net income (expense)
45.12%-30.41M
-3,875.74%-12.76M
-52.61%-73.54M
-56.17%-75.5M
568.50%849K
-154,005.56%-55.41M
6,860.00%338K
-688,471.43%-48.19M
-48.34M
4,133.33%127K
Gain on sale of security
44.33%-31.27M
---13.34M
---76.21M
----
----
---56.18M
----
----
----
----
Special income (charges)
----
----
--0
----
----
----
----
---48.65M
----
----
-Less:Impairment of capital assets
----
----
--0
----
----
----
----
--48.65M
----
----
Other non- operating income (expenses)
12.13%869K
69.82%574K
478.79%2.67M
134.21%712K
568.50%849K
2,052.78%775K
6,860.00%338K
6,500.00%462K
--304K
4,133.33%127K
Income before tax
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
-47.02%-85.84M
1.17%-10.35M
-611.15%-65.76M
-9.21%-10.77M
-138.65%-87.97M
-522.10%-58.38M
0.30%-10.47M
Income tax
Net income
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
-47.02%-85.84M
1.17%-10.35M
-611.15%-65.76M
-9.21%-10.77M
-154.93%-87.97M
-563.00%-58.38M
-6.66%-10.47M
Net income continuous Operations
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
-47.02%-85.84M
1.17%-10.35M
-611.15%-65.76M
-9.21%-10.77M
-154.93%-87.97M
-563.00%-58.38M
-6.66%-10.47M
Minority interest income
Net income attributable to the parent company
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
-47.02%-85.84M
1.17%-10.35M
-611.15%-65.76M
-9.21%-10.77M
-154.93%-87.97M
-563.00%-58.38M
-6.66%-10.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
-47.02%-85.84M
1.17%-10.35M
-611.15%-65.76M
-9.21%-10.77M
-154.93%-87.97M
-563.00%-58.38M
-6.66%-10.47M
Basic earnings per share
61.31%-1.06
-5.33%-0.79
23.21%-4.73
17.36%-3.38
52.05%-0.35
-321.54%-2.74
-8.70%-0.75
-164.38%-6.16
-581.67%-4.09
-10.61%-0.73
Diluted earnings per share
61.31%-1.06
-5.33%-0.79
23.21%-4.73
17.36%-3.38
52.05%-0.35
-321.54%-2.74
-8.70%-0.75
-164.38%-6.16
-581.67%-4.09
-10.61%-0.73
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 40.06%14.5M-2.17%10.87M8.09%43M2.97%10.34M5.66%11.2M11.54%10.35M12.69%11.11M7.90%39.78M6.98%10.04M0.88%10.6M
Selling and administrative expenses 39.42%4.4M15.42%3.46M-0.09%12.69M17.24%3.27M3.85%3.27M-10.93%3.15M-7.04%3M-3.29%12.7M-12.89%2.79M10.46%3.15M
-General and administrative expense 39.42%4.4M15.42%3.46M-0.09%12.69M17.24%3.27M3.85%3.27M-10.93%3.15M-7.04%3M-3.29%12.7M-12.89%2.79M10.46%3.15M
Research and development costs 40.34%10.11M-8.67%7.41M11.94%30.31M-2.52%7.07M6.43%7.93M25.39%7.2M22.28%8.11M14.09%27.08M17.28%7.25M-2.69%7.45M
Operating profit -40.06%-14.5M2.17%-10.87M-8.09%-43M-2.97%-10.34M-5.66%-11.2M-11.54%-10.35M-12.69%-11.11M-7.90%-39.78M-6.98%-10.04M-0.88%-10.6M
Net non-operating interest income expense
Other net income (expense) 45.12%-30.41M-3,875.74%-12.76M-52.61%-73.54M-56.17%-75.5M568.50%849K-154,005.56%-55.41M6,860.00%338K-688,471.43%-48.19M-48.34M4,133.33%127K
Gain on sale of security 44.33%-31.27M---13.34M---76.21M-----------56.18M----------------
Special income (charges) ----------0-------------------48.65M--------
-Less:Impairment of capital assets ----------0------------------48.65M--------
Other non- operating income (expenses) 12.13%869K69.82%574K478.79%2.67M134.21%712K568.50%849K2,052.78%775K6,860.00%338K6,500.00%462K--304K4,133.33%127K
Income before tax 31.71%-44.91M-119.37%-23.63M-32.48%-116.54M-47.02%-85.84M1.17%-10.35M-611.15%-65.76M-9.21%-10.77M-138.65%-87.97M-522.10%-58.38M0.30%-10.47M
Income tax
Net income 31.71%-44.91M-119.37%-23.63M-32.48%-116.54M-47.02%-85.84M1.17%-10.35M-611.15%-65.76M-9.21%-10.77M-154.93%-87.97M-563.00%-58.38M-6.66%-10.47M
Net income continuous Operations 31.71%-44.91M-119.37%-23.63M-32.48%-116.54M-47.02%-85.84M1.17%-10.35M-611.15%-65.76M-9.21%-10.77M-154.93%-87.97M-563.00%-58.38M-6.66%-10.47M
Minority interest income
Net income attributable to the parent company 31.71%-44.91M-119.37%-23.63M-32.48%-116.54M-47.02%-85.84M1.17%-10.35M-611.15%-65.76M-9.21%-10.77M-154.93%-87.97M-563.00%-58.38M-6.66%-10.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 31.71%-44.91M-119.37%-23.63M-32.48%-116.54M-47.02%-85.84M1.17%-10.35M-611.15%-65.76M-9.21%-10.77M-154.93%-87.97M-563.00%-58.38M-6.66%-10.47M
Basic earnings per share 61.31%-1.06-5.33%-0.7923.21%-4.7317.36%-3.3852.05%-0.35-321.54%-2.74-8.70%-0.75-164.38%-6.16-581.67%-4.09-10.61%-0.73
Diluted earnings per share 61.31%-1.06-5.33%-0.7923.21%-4.7317.36%-3.3852.05%-0.35-321.54%-2.74-8.70%-0.75-164.38%-6.16-581.67%-4.09-10.61%-0.73
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data